Stock 4555 SAWAI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Sawai Pharmaceutical Co., Ltd. Japan Exchange

Equities

4555

JP3323050009

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sawai Group Plans 33 Billion Yen Share Buyback; Shares Up 8%
MT
Sawai Group Holdings Co., Ltd. announces an Equity Buyback for 6,900,000 shares, representing 15.75% for ¥33,000 million.
CI
Sawai Group Holdings Co., Ltd. authorizes a Buyback Plan.
CI
Transcript : Sawai Group Holdings Co., Ltd. - Special Call
Transcript : Sawai Group Holdings Co., Ltd., 2024 Earnings Call, May 14, 2024
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2024 and Fiscal Year Ending March 2025
CI
Sawai Group Holdings Co., Ltd. Announces Dividend Guidance for the Second Quarter and Fiscal Year Ending March 31, 2025
CI
Sawai Group Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 26, 2024
CI
Sawai Group Finalizes Sale of US Subsidiary
MT
Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd..
CI
Jefferies Adjusts Sawai Group’s Price Target to 5,000 Yen From 5,200 Yen, Keeps at Hold
MT
Sawai Group Holdings Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2024
CI
Sawai Group Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
CI
Notice of Transfer of Sawai's U.S. Subsidiary, Sub-subsidiary
AQ
Bora Pharmaceuticals Co., LTD. agreed to acquire Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd. for approximately $210 million.
CI
Neurolief Announces Strategic Equity Investment by Sawai Group Holdings
AQ
Neurolief Ltd. announced that it has received funding from Sawai Group Holdings Co., Ltd.
CI
Jefferies Adjusts Sawai’s Price Target to 4,500 Yen From 3,500 Yen, Keeps at Hold
MT
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
CI
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4887 Stock
  4. 4555 Stock
  5. News Sawai Pharmaceutical Co., Ltd.